TrialCirculation2016

Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.

Michelle L O'Donoghue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.